Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

Clinical trial NCT01362205 · TERMINATED

Trial details

NCT number: NCT01362205
Sponsor: Denver Health and Hospital Authority
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Alcohol Withdrawal Delirium Alcohol Withdrawal Associated Autonomic Hyperactivity Alcohol Withdrawal Hallucinosis Alcohol Withdrawal-Induced Delirium Tremens

Start date: 2012-03-01
Primary completion: 2015-12-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.